| Organism
|
Antimicrobial Options
|
| MSSA
|
nafcillin 2 g IV q4h
|
| oxacillin 2 g IV q4h
|
| cefazolin 2 g IV q8h
|
| flucloxacillin 2 g IV q6h
|
| ceftriaxone 2 g IV q24h
|
| MRSA
|
vancomycin 20 mg/kg load followed by 15-20 mg IV q8-12h
|
| daptomycin 6 to 10 mg/kg IV daily
|
| teicoplanin 12 mg/kg IV q12h for 3 to 5 doses followed by q24h
|
| Adjunctive staphylococcal agent
|
rifampin 300 to 450 mg PO bid
|
| fusidic acid 500 mg PO tid
|
| Gram-negative bacteria
|
ciprofloxacin 750 mg PO big to 400 mg IV q12h
|
| levofloxacin 750 mg PO/IV daily
|
| ceftriaxone 2 g IV q24h
|
| ceftazidime 2 g IV q8h
|
| cefepime 2 g IV q8-12h
|
| ertapenem 1 g IV q24h
|
| meropenem 1 g IV q8h
|
| Pseudomonas aeruginosa
|
ciprofloxacin 400 mg IV q8h
|
| Enterococcus species
|
ampicillin 12 g continuous IV q24h
|
| ampicillin 2 g IV q4h
|
| penicillin G 20 to 24 million units continuous IV q24h
|
| penicillin G 3-4 million units IV q4h
|
| vancomycin 20 mg/kg IV load followed by 15 mg/kg IV q12h (max 2 g per dose)
|
| daptomycin 6 to 10 mg/kg IV daily
|
| teicoplanin 12 mg/kg IV q12h for 3 to 5 doses, followed by q24h
|
| ampicillin as above, PLUS ceftriaxone 2 g IV q12-24h
|
| penicillin-susceptible streptococci
|
ampicillin 12 g continuous IV q24h
|
| ampicillin 2 g IV q4h
|
| penicillin G 20 to 24 million units continuous IV q24h
|
| penicillin G 3-4 million units IV q4h
|
| ceftriaxone 2 g IV q24h
|
| vancomycin 20 mg/kg IV load followed by 15 mg/kg IV q12h (max 2 g per dose)
|
| Cutibacterium acnes
|
penicillin G 20 to 24 million units continuous IV q24h
|
| penicillin G 3-4 million units IV q4h
|
| ceftriaxone 2 g IV q24h
|